Top Markets
Coin of the day
Blue Water Vaccines, Inc. Blue Water Vaccines, Inc.

Blue Water Vaccines, Inc.

BWV
Rang in Aktien #36371
Blue Water Vaccines, Inc. (BWV) operates as a biotechnology firm dedicated to... Blue Water Vaccines, Inc. (BWV) operates as a biotechnology firm dedicated to the worldwide discovery and development of vaccines aimed at preventing infectious diseases. Currently in preclinical stages, their most prominent vaccine candidates are BWV-101, an influenza shot, and BWV-102, designed to counter H1 pre-pandemic threats. The company's developmental portfolio also includes other preclinical programs such as BWV-201, a vaccine addressing acute otitis media caused by Streptococcus pneumoniae; BWV-301, a combined vaccine for norovirus and rotavirus; and BWV-302, a dual-target vaccine for norovirus and malaria. Founded in 2018, BWV's operations are based in Cincinnati, Ohio.
Aktienkurs
$0.1735
Zuletzt synchronisiert: 2024-01-16
Marktkapitalisierung
$2.76M
Veränderung (1 Tag)
-3.82%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Blue Water Vaccines, Inc. (BWV)

Kategorie

Dividendenrendite-Verlauf für Blue Water Vaccines, Inc. (BWV)
Dividendenrendite (TTM) von Blue Water Vaccines, Inc. (Aktienkürzel: BWV) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Blue Water Vaccines, Inc. (BWV) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber